The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that Arixtra patients will be less likely to experience wound
infection than patients who have received low-molecular weight heparin, coumadin or aspirin
with mechanical compression.